| 0 |
APPLICATION SITE GRANULOMA |
1 |
0.5000 |
| 1 |
DELAYED MENARCHE |
6 |
0.3529 |
| 2 |
PREMATURE MENARCHE |
7 |
0.2258 |
| 3 |
IMPLANT SITE HYPERTROPHY |
2 |
0.2222 |
| 4 |
EARLY MENARCHE |
2 |
0.1429 |
| 5 |
ADMINISTRATION SITE SCAB |
3 |
0.1154 |
| 6 |
IMPLANT SITE RASH |
41 |
0.1145 |
| 7 |
IMPLANT SITE DERMATITIS |
2 |
0.1111 |
| 8 |
PUBERTY |
6 |
0.1053 |
| 9 |
MENARCHE |
2 |
0.1053 |
| 10 |
INCISION SITE RASH |
5 |
0.0833 |
| 11 |
BLOOD GONADOTROPHIN INCREASED |
2 |
0.0800 |
| 12 |
DELAYED PUBERTY |
19 |
0.0748 |
| 13 |
IMPLANT SITE URTICARIA |
6 |
0.0612 |
| 14 |
GROWTH ACCELERATED |
12 |
0.0556 |
| 15 |
IMPLANT SITE NODULE |
2 |
0.0476 |
| 16 |
DEVICE EXTRUSION |
9 |
0.0423 |
| 17 |
IMPLANT SITE PAPULES |
1 |
0.0417 |
| 18 |
IMPLANT SITE VESICLES |
6 |
0.0408 |
| 19 |
IMPLANT SITE PUSTULES |
2 |
0.0328 |
| 20 |
BILATERAL BREAST BUDS |
1 |
0.0294 |
| 21 |
SCAR INFLAMMATION |
1 |
0.0286 |
| 22 |
IMPLANT SITE ABSCESS |
5 |
0.0259 |
| 23 |
BLOOD LUTEINISING HORMONE INCREASED |
6 |
0.0244 |
| 24 |
TESTICULAR HYPERTROPHY |
1 |
0.0217 |
| 25 |
IMPLANT SITE IRRITATION |
8 |
0.0211 |
| 26 |
FLUCTUANCE |
1 |
0.0204 |
| 27 |
BLOOD LUTEINISING HORMONE ABNORMAL |
1 |
0.0196 |
| 28 |
IMPLANT SITE DISCHARGE |
7 |
0.0187 |
| 29 |
INJECTION SITE ABSCESS STERILE |
2 |
0.0177 |
| 30 |
IMPLANT SITE INDURATION |
2 |
0.0175 |
| 31 |
IMPLANT SITE CELLULITIS |
4 |
0.0171 |
| 32 |
OESTRADIOL INCREASED |
5 |
0.0166 |
| 33 |
IMPLANT SITE ERYTHEMA |
16 |
0.0154 |
| 34 |
BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL |
1 |
0.0154 |
| 35 |
MEDICAL DEVICE SITE SCAB |
1 |
0.0137 |
| 36 |
ABSCESS STERILE |
2 |
0.0135 |
| 37 |
IMPLANT SITE PARAESTHESIA |
2 |
0.0133 |
| 38 |
BRACHIAL PLEXUS INJURY |
2 |
0.0124 |
| 39 |
RETINAL MIGRAINE |
1 |
0.0123 |
| 40 |
INCISION SITE PRURITUS |
1 |
0.0119 |
| 41 |
ASTROCYTOMA, LOW GRADE |
2 |
0.0118 |
| 42 |
EXPULSION OF MEDICATION |
6 |
0.0113 |
| 43 |
PROCEDURAL COMPLICATION |
83 |
0.0108 |
| 44 |
LEUKODYSTROPHY |
1 |
0.0108 |
| 45 |
IMPLANT SITE BRUISING |
8 |
0.0107 |
| 46 |
IMPLANT SITE OEDEMA |
1 |
0.0103 |
| 47 |
HEPATOBLASTOMA |
1 |
0.0103 |
| 48 |
IMPLANT SITE INFECTION |
23 |
0.0099 |
| 49 |
IMPLANT SITE SWELLING |
10 |
0.0098 |
| 50 |
NEUROFIBROSARCOMA |
1 |
0.0097 |
| 51 |
CORNEAL OPERATION |
1 |
0.0097 |
| 52 |
ENCAPSULATION REACTION |
1 |
0.0097 |
| 53 |
PITUITARY CYST |
1 |
0.0090 |
| 54 |
IMPLANT SITE PRURITUS |
8 |
0.0089 |
| 55 |
OSTEOCHONDROMA |
1 |
0.0084 |
| 56 |
ULNAR NERVE INJURY |
2 |
0.0083 |
| 57 |
IMPLANT SITE SCAR |
6 |
0.0080 |
| 58 |
INSTILLATION SITE DISCOMFORT |
1 |
0.0075 |
| 59 |
PRECOCIOUS PUBERTY |
4 |
0.0070 |
| 60 |
IMPLANT SITE INFLAMMATION |
2 |
0.0068 |
| 61 |
BREAST ENLARGEMENT |
22 |
0.0067 |
| 62 |
IMPLANT SITE REACTION |
3 |
0.0066 |
| 63 |
INCISION SITE SWELLING |
2 |
0.0066 |
| 64 |
IMPLANT SITE DISCOLOURATION |
1 |
0.0065 |
| 65 |
IMPLANT SITE WARMTH |
1 |
0.0065 |
| 66 |
BREAST DISCOLOURATION |
1 |
0.0063 |
| 67 |
APPLICATION SITE WOUND |
1 |
0.0061 |
| 68 |
IMPLANT SITE PAIN |
27 |
0.0060 |
| 69 |
BLOOD COPPER INCREASED |
1 |
0.0056 |
| 70 |
ADMINISTRATION SITE DISCOMFORT |
1 |
0.0053 |
| 71 |
IDIOPATHIC ORBITAL INFLAMMATION |
1 |
0.0052 |
| 72 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
2 |
0.0051 |
| 73 |
ASTROCYTOMA |
2 |
0.0051 |
| 74 |
IMPLANTATION COMPLICATION |
1 |
0.0048 |
| 75 |
IMPLANT SITE HYPOAESTHESIA |
1 |
0.0047 |
| 76 |
INCISION SITE ERYTHEMA |
2 |
0.0043 |
| 77 |
BODY HEIGHT INCREASED |
2 |
0.0041 |
| 78 |
EPIPHYSIOLYSIS |
1 |
0.0040 |
| 79 |
SHORT STATURE |
1 |
0.0038 |
| 80 |
MIGRATION OF IMPLANTED DRUG |
2 |
0.0038 |
| 81 |
GROWTH DISORDER |
1 |
0.0037 |
| 82 |
VICTIM OF ABUSE |
1 |
0.0037 |
| 83 |
SHUNT MALFUNCTION |
1 |
0.0035 |
| 84 |
IMPLANT SITE EROSION |
1 |
0.0034 |
| 85 |
TEETHING |
1 |
0.0033 |
| 86 |
BLOOD TESTOSTERONE INCREASED |
7 |
0.0033 |
| 87 |
WOUND INFECTION PSEUDOMONAS |
1 |
0.0032 |
| 88 |
IMMUNOGLOBULIN G4 RELATED DISEASE |
1 |
0.0031 |
| 89 |
MENSTRUATION NORMAL |
1 |
0.0030 |
| 90 |
PROCEDURAL ANXIETY |
2 |
0.0029 |
| 91 |
PATIENT-DEVICE INCOMPATIBILITY |
2 |
0.0029 |
| 92 |
HYPERALDOSTERONISM |
1 |
0.0029 |
| 93 |
DEVICE BREAKAGE |
117 |
0.0029 |
| 94 |
TRANSIENT GLOBAL AMNESIA |
2 |
0.0028 |
| 95 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
60 |
0.0028 |
| 96 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 97 |
INCISION SITE COMPLICATION |
2 |
0.0024 |
| 98 |
INCORRECT DRUG ADMINISTRATION DURATION |
65 |
0.0023 |
| 99 |
SKIN LAXITY |
1 |
0.0023 |
| 100 |
IMPLANT SITE HAEMORRHAGE |
1 |
0.0023 |
| 101 |
THERAPEUTIC PRODUCT EFFECT PROLONGED |
1 |
0.0022 |
| 102 |
DERMATITIS INFECTED |
1 |
0.0020 |
| 103 |
IMPLANT SITE FIBROSIS |
1 |
0.0020 |
| 104 |
SHUNT OCCLUSION |
1 |
0.0020 |
| 105 |
KELOID SCAR |
1 |
0.0019 |
| 106 |
MEDICAL DEVICE SITE PAIN |
1 |
0.0018 |
| 107 |
OSTEOGENESIS IMPERFECTA |
1 |
0.0017 |
| 108 |
INCISION SITE PAIN |
2 |
0.0017 |
| 109 |
HAIR GROWTH ABNORMAL |
11 |
0.0016 |
| 110 |
CORNEAL PERFORATION |
1 |
0.0016 |
| 111 |
SEROMA |
2 |
0.0016 |
| 112 |
SUTURE RELATED COMPLICATION |
1 |
0.0014 |
| 113 |
ALPHA 1 FOETOPROTEIN INCREASED |
1 |
0.0014 |
| 114 |
FAT TISSUE INCREASED |
2 |
0.0014 |
| 115 |
WITHDRAWAL BLEED |
1 |
0.0014 |
| 116 |
ATROPHIC VULVOVAGINITIS |
1 |
0.0014 |
| 117 |
LEGAL PROBLEM |
1 |
0.0014 |
| 118 |
PITUITARY TUMOUR |
2 |
0.0013 |
| 119 |
TENDON DISCOMFORT |
1 |
0.0013 |
| 120 |
INFECTION PARASITIC |
1 |
0.0013 |
| 121 |
PRODUCT INEFFECTIVE |
1 |
0.0013 |
| 122 |
IMPLANT SITE EXTRAVASATION |
1 |
0.0013 |
| 123 |
WOUND DRAINAGE |
1 |
0.0013 |
| 124 |
EXCESSIVE GRANULATION TISSUE |
1 |
0.0012 |
| 125 |
INCISION SITE HAEMORRHAGE |
1 |
0.0012 |
| 126 |
MYCOSIS FUNGOIDES |
1 |
0.0012 |
| 127 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 128 |
WOUND DEHISCENCE |
4 |
0.0012 |
| 129 |
PROTEIN URINE |
1 |
0.0011 |
| 130 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0011 |
| 131 |
APPLICATION SITE DERMATITIS |
1 |
0.0011 |
| 132 |
DERMATITIS CONTACT |
12 |
0.0011 |
| 133 |
LIPOATROPHY |
1 |
0.0011 |
| 134 |
INJECTION SITE SCAB |
1 |
0.0010 |
| 135 |
ANTISOCIAL BEHAVIOUR |
1 |
0.0010 |
| 136 |
INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT |
1 |
0.0010 |
| 137 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0010 |
| 138 |
BONE NEOPLASM |
1 |
0.0009 |
| 139 |
BLOOD TESTOSTERONE ABNORMAL |
1 |
0.0009 |
| 140 |
COMPLEX PARTIAL SEIZURES |
1 |
0.0009 |
| 141 |
THYROTOXIC CRISIS |
1 |
0.0009 |
| 142 |
MOOD SWINGS |
28 |
0.0009 |
| 143 |
MACROCYTOSIS |
1 |
0.0009 |
| 144 |
OSTEOCHONDROSIS |
1 |
0.0009 |
| 145 |
HORMONE LEVEL ABNORMAL |
4 |
0.0008 |
| 146 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 147 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 148 |
ENDOCRINE DISORDER |
1 |
0.0008 |
| 149 |
IATROGENIC INJURY |
1 |
0.0008 |
| 150 |
ENURESIS |
3 |
0.0007 |
| 151 |
MENSTRUATION DELAYED |
8 |
0.0007 |
| 152 |
PREMENSTRUAL SYNDROME |
1 |
0.0007 |
| 153 |
COMPLICATION OF DEVICE REMOVAL |
13 |
0.0007 |
| 154 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 155 |
ACUTE ABDOMEN |
1 |
0.0007 |
| 156 |
IMPETIGO |
1 |
0.0007 |
| 157 |
POLYCYSTIC OVARIES |
1 |
0.0006 |
| 158 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 159 |
PITUITARY TUMOUR BENIGN |
1 |
0.0006 |
| 160 |
BREAST MASS |
4 |
0.0006 |
| 161 |
MILIARIA |
1 |
0.0006 |
| 162 |
MEDICAL DEVICE REMOVAL |
1 |
0.0006 |
| 163 |
TREATMENT DELAYED |
1 |
0.0006 |
| 164 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
0.0006 |
| 165 |
KYPHOSIS |
1 |
0.0006 |
| 166 |
BREAST CYST |
1 |
0.0006 |
| 167 |
HYPERTRICHOSIS |
1 |
0.0005 |
| 168 |
INTERMENSTRUAL BLEEDING |
3 |
0.0005 |
| 169 |
BLADDER SPASM |
1 |
0.0005 |
| 170 |
SCAR |
9 |
0.0005 |
| 171 |
AFFECT LABILITY |
5 |
0.0005 |
| 172 |
DEVICE DISLOCATION |
22 |
0.0005 |
| 173 |
DIPLEGIA |
1 |
0.0005 |
| 174 |
NIPPLE PAIN |
1 |
0.0005 |
| 175 |
VASCULAR OCCLUSION |
1 |
0.0005 |
| 176 |
EAR SWELLING |
1 |
0.0005 |
| 177 |
RASH GENERALISED |
12 |
0.0005 |
| 178 |
HENOCH-SCHONLEIN PURPURA |
1 |
0.0005 |
| 179 |
LIMB MASS |
1 |
0.0005 |
| 180 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 181 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 182 |
FEAR OF DEATH |
1 |
0.0004 |
| 183 |
RASH PRURITIC |
23 |
0.0004 |
| 184 |
VOLVULUS |
1 |
0.0004 |
| 185 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0004 |
| 186 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 187 |
DEVICE EXPULSION |
27 |
0.0004 |
| 188 |
STARING |
1 |
0.0004 |
| 189 |
PLATELET DISORDER |
1 |
0.0004 |
| 190 |
VAGINAL DISCHARGE |
4 |
0.0004 |
| 191 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 192 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
2 |
0.0004 |
| 193 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 194 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 195 |
STRABISMUS |
1 |
0.0003 |
| 196 |
GROWTH RETARDATION |
1 |
0.0003 |
| 197 |
BRAIN HERNIATION |
1 |
0.0003 |
| 198 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 199 |
BRAIN NEOPLASM |
3 |
0.0003 |
| 200 |
BRAIN DEATH |
1 |
0.0003 |
| 201 |
PERSONALITY CHANGE |
3 |
0.0003 |
| 202 |
DRUG EFFECT INCREASED |
1 |
0.0003 |
| 203 |
APPLICATION SITE VESICLES |
2 |
0.0003 |
| 204 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 205 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 206 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 207 |
DEVICE DEFECTIVE |
5 |
0.0003 |
| 208 |
HYPOPNOEA |
1 |
0.0003 |
| 209 |
EAR PRURITUS |
1 |
0.0003 |
| 210 |
DEVICE PLACEMENT ISSUE |
1 |
0.0003 |
| 211 |
PHARYNGITIS STREPTOCOCCAL |
3 |
0.0003 |
| 212 |
DEVICE KINK |
1 |
0.0003 |
| 213 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 214 |
NERVE INJURY |
3 |
0.0003 |
| 215 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 216 |
PANIC DISORDER |
1 |
0.0003 |
| 217 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 218 |
MOOD ALTERED |
7 |
0.0003 |
| 219 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 220 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 221 |
UPPER LIMB FRACTURE |
5 |
0.0003 |
| 222 |
GOITRE |
1 |
0.0002 |
| 223 |
ERECTION INCREASED |
1 |
0.0002 |
| 224 |
SELF-INJURIOUS IDEATION |
1 |
0.0002 |
| 225 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 226 |
CHAPPED LIPS |
1 |
0.0002 |
| 227 |
AMENORRHOEA |
4 |
0.0002 |
| 228 |
DYSPHEMIA |
1 |
0.0002 |
| 229 |
PARONYCHIA |
1 |
0.0002 |
| 230 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 231 |
BRAIN NEOPLASM MALIGNANT |
1 |
0.0002 |
| 232 |
DRUG EFFECT DECREASED |
12 |
0.0002 |
| 233 |
DRUG EFFECT DELAYED |
1 |
0.0002 |
| 234 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 235 |
RASH VESICULAR |
1 |
0.0002 |
| 236 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 237 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 238 |
OVARIAN CYST |
2 |
0.0002 |
| 239 |
AGGRESSION |
10 |
0.0002 |
| 240 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 241 |
WEIGHT LOSS POOR |
1 |
0.0002 |
| 242 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 243 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 244 |
BREAST PAIN |
2 |
0.0002 |
| 245 |
OVERWEIGHT |
1 |
0.0002 |
| 246 |
HIP SURGERY |
1 |
0.0002 |
| 247 |
HYDROCEPHALUS |
1 |
0.0002 |
| 248 |
TIC |
1 |
0.0002 |
| 249 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 250 |
RASH PAPULAR |
4 |
0.0002 |
| 251 |
ABNORMAL BEHAVIOUR |
7 |
0.0002 |
| 252 |
SCAB |
2 |
0.0002 |
| 253 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 254 |
SKIN WARM |
1 |
0.0002 |
| 255 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 256 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 257 |
MENISCUS INJURY |
1 |
0.0002 |
| 258 |
EMOTIONAL DISORDER |
5 |
0.0002 |
| 259 |
SCOLIOSIS |
1 |
0.0002 |
| 260 |
CYST |
2 |
0.0002 |
| 261 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 262 |
DEVICE DEPLOYMENT ISSUE |
2 |
0.0002 |
| 263 |
SOMNAMBULISM |
1 |
0.0002 |
| 264 |
DYSMENORRHOEA |
2 |
0.0002 |
| 265 |
SKIN MASS |
1 |
0.0001 |
| 266 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 267 |
WEIGHT INCREASED |
31 |
0.0001 |
| 268 |
SWELLING FACE |
9 |
0.0001 |
| 269 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 270 |
MEDICAL DEVICE COMPLICATION |
1 |
0.0001 |
| 271 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 272 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 273 |
SUNBURN |
1 |
0.0001 |
| 274 |
BREAST TENDERNESS |
1 |
0.0001 |
| 275 |
DEVICE FAILURE |
2 |
0.0001 |
| 276 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 277 |
SEIZURE |
15 |
0.0001 |
| 278 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 279 |
GINGIVAL PAIN |
1 |
0.0001 |
| 280 |
ABSCESS |
2 |
0.0001 |
| 281 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 282 |
IMPAIRED HEALING |
4 |
0.0001 |
| 283 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 284 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 285 |
HOT FLUSH |
9 |
0.0001 |
| 286 |
ANGER |
4 |
0.0001 |
| 287 |
METRORRHAGIA |
2 |
0.0001 |
| 288 |
IRRITABILITY |
7 |
0.0001 |
| 289 |
VAGINAL HAEMORRHAGE |
5 |
0.0001 |
| 290 |
GROIN PAIN |
1 |
0.0001 |
| 291 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 292 |
MENSTRUATION IRREGULAR |
3 |
0.0001 |
| 293 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 294 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 295 |
DEFORMITY |
1 |
0.0001 |
| 296 |
RASH |
46 |
0.0001 |
| 297 |
DRUG INEFFECTIVE |
138 |
0.0001 |
| 298 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 299 |
DRUG PRESCRIBING ERROR |
2 |
0.0001 |
| 300 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 301 |
THERAPY CHANGE |
1 |
0.0001 |
| 302 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 303 |
SLUGGISHNESS |
1 |
0.0001 |
| 304 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 305 |
TENDERNESS |
1 |
0.0001 |
| 306 |
URTICARIA |
16 |
0.0001 |
| 307 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 308 |
RENAL PAIN |
1 |
0.0001 |
| 309 |
JOINT INJURY |
2 |
0.0001 |
| 310 |
NIGHT SWEATS |
3 |
0.0001 |
| 311 |
ACNE |
7 |
0.0001 |
| 312 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 313 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 314 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 315 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 316 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 317 |
PERIPHERAL SWELLING |
13 |
0.0001 |
| 318 |
ACCIDENT |
1 |
0.0001 |
| 319 |
CRYING |
3 |
0.0001 |
| 320 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 321 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 322 |
BRAIN OEDEMA |
1 |
0.0001 |
| 323 |
ECZEMA |
4 |
0.0001 |
| 324 |
ADVERSE REACTION |
1 |
0.0001 |
| 325 |
BLINDNESS |
3 |
0.0001 |
| 326 |
PALLOR |
2 |
0.0001 |
| 327 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 328 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 329 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 330 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 331 |
DEVICE MALFUNCTION |
5 |
0.0001 |
| 332 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 333 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
5 |
0.0001 |
| 334 |
CONVULSION |
4 |
0.0001 |
| 335 |
HYPERSOMNIA |
2 |
0.0001 |
| 336 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 337 |
HYPOKINESIA |
1 |
0.0001 |
| 338 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 339 |
APATHY |
1 |
0.0001 |
| 340 |
GASTROENTERITIS |
1 |
0.0001 |
| 341 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 342 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 343 |
DEVICE ISSUE |
6 |
0.0001 |
| 344 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 345 |
THYROID DISORDER |
1 |
0.0001 |
| 346 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 347 |
ANKLE FRACTURE |
1 |
0.0001 |
| 348 |
MENINGIOMA |
1 |
0.0001 |
| 349 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 350 |
HEADACHE |
39 |
0.0001 |
| 351 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 352 |
LIP SWELLING |
2 |
0.0001 |
| 353 |
COAGULOPATHY |
1 |
0.0001 |
| 354 |
FUNGAL INFECTION |
2 |
0.0001 |
| 355 |
LOCAL SWELLING |
1 |
0.0001 |
| 356 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 357 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 358 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 359 |
THIRST |
1 |
0.0001 |
| 360 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
10 |
0.0001 |
| 361 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 362 |
SUICIDAL IDEATION |
5 |
0.0001 |
| 363 |
SWELLING |
5 |
0.0001 |
| 364 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 365 |
INCREASED APPETITE |
1 |
0.0001 |
| 366 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 367 |
PRODUCT QUALITY ISSUE |
7 |
0.0001 |
| 368 |
SKIN FISSURES |
1 |
0.0001 |
| 369 |
KIDNEY INFECTION |
1 |
0.0001 |
| 370 |
COMPLICATION OF DEVICE INSERTION |
1 |
0.0001 |
| 371 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 372 |
ABDOMINAL PAIN UPPER |
10 |
0.0000 |
| 373 |
DERMATITIS |
1 |
0.0000 |
| 374 |
MOUTH ULCERATION |
1 |
0.0000 |
| 375 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 376 |
RETCHING |
1 |
0.0000 |
| 377 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 378 |
NO ADVERSE EVENT |
8 |
0.0000 |
| 379 |
ERYTHEMA |
9 |
0.0000 |
| 380 |
SKIN IRRITATION |
2 |
0.0000 |
| 381 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 382 |
SLEEP DISORDER |
3 |
0.0000 |
| 383 |
HYPERTENSION |
9 |
0.0000 |
| 384 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 385 |
PRESYNCOPE |
1 |
0.0000 |
| 386 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 387 |
THERAPY CESSATION |
2 |
0.0000 |
| 388 |
OFF LABEL USE |
34 |
0.0000 |
| 389 |
ANXIETY |
11 |
0.0000 |
| 390 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 391 |
NERVOUSNESS |
2 |
0.0000 |
| 392 |
DEAFNESS |
1 |
0.0000 |
| 393 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 394 |
JOINT STIFFNESS |
1 |
0.0000 |
| 395 |
EAR INFECTION |
1 |
0.0000 |
| 396 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 397 |
LIMB INJURY |
1 |
0.0000 |
| 398 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 399 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 400 |
VISION BLURRED |
5 |
0.0000 |
| 401 |
CONDITION AGGRAVATED |
11 |
0.0000 |
| 402 |
NECK PAIN |
2 |
0.0000 |
| 403 |
WOUND |
1 |
0.0000 |
| 404 |
DEPRESSION |
8 |
0.0000 |
| 405 |
LETHARGY |
2 |
0.0000 |
| 406 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 407 |
ABDOMINAL PAIN |
8 |
0.0000 |
| 408 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 409 |
BONE PAIN |
2 |
0.0000 |
| 410 |
SURGERY |
2 |
0.0000 |
| 411 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 412 |
PRURITUS |
13 |
0.0000 |
| 413 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 414 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 415 |
DISCOMFORT |
2 |
0.0000 |
| 416 |
EPILEPSY |
1 |
0.0000 |
| 417 |
FEELING HOT |
2 |
0.0000 |
| 418 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 419 |
ADVERSE EVENT |
3 |
0.0000 |
| 420 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 421 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 422 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 423 |
MIGRAINE |
3 |
0.0000 |
| 424 |
CYSTITIS |
1 |
0.0000 |
| 425 |
ALOPECIA |
6 |
0.0000 |
| 426 |
DEVICE DIFFICULT TO USE |
2 |
0.0000 |
| 427 |
INSOMNIA |
8 |
0.0000 |
| 428 |
SKIN DISORDER |
1 |
0.0000 |
| 429 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 430 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 431 |
HAEMATURIA |
1 |
0.0000 |
| 432 |
DEVICE USE ERROR |
1 |
0.0000 |
| 433 |
RASH MACULAR |
1 |
0.0000 |
| 434 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 435 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 436 |
VOMITING |
13 |
0.0000 |
| 437 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 438 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 439 |
PANIC ATTACK |
1 |
0.0000 |
| 440 |
EYE SWELLING |
1 |
0.0000 |
| 441 |
HALLUCINATION |
2 |
0.0000 |
| 442 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 443 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 444 |
DIZZINESS |
13 |
0.0000 |
| 445 |
PYREXIA |
9 |
0.0000 |
| 446 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 447 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 448 |
THROMBOSIS |
2 |
0.0000 |
| 449 |
PNEUMONIA |
8 |
0.0000 |
| 450 |
DYSKINESIA |
1 |
0.0000 |
| 451 |
OSTEOPOROSIS |
1 |
0.0000 |
| 452 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 453 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 454 |
FALL |
8 |
0.0000 |
| 455 |
POLLAKIURIA |
1 |
0.0000 |
| 456 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 457 |
HYPERHIDROSIS |
3 |
0.0000 |
| 458 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 459 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 460 |
MENTAL DISORDER |
1 |
0.0000 |
| 461 |
CONSTIPATION |
5 |
0.0000 |
| 462 |
DRY SKIN |
3 |
0.0000 |
| 463 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 464 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 465 |
THROAT IRRITATION |
1 |
0.0000 |
| 466 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 467 |
TINNITUS |
1 |
0.0000 |
| 468 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 469 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 470 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 471 |
INFECTION |
3 |
0.0000 |
| 472 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 473 |
LUNG DISORDER |
1 |
0.0000 |
| 474 |
HEART RATE INCREASED |
2 |
0.0000 |
| 475 |
HYPOAESTHESIA |
3 |
0.0000 |
| 476 |
DRY EYE |
1 |
0.0000 |
| 477 |
CELLULITIS |
1 |
0.0000 |
| 478 |
INFLAMMATION |
1 |
0.0000 |
| 479 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 480 |
PARAESTHESIA |
3 |
0.0000 |
| 481 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 482 |
DEPRESSED MOOD |
1 |
0.0000 |
| 483 |
DEATH |
16 |
0.0000 |
| 484 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 485 |
MALAISE |
8 |
0.0000 |
| 486 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 487 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 488 |
SEPSIS |
2 |
0.0000 |
| 489 |
EYE PAIN |
1 |
0.0000 |
| 490 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 491 |
BACK PAIN |
4 |
0.0000 |
| 492 |
NASAL CONGESTION |
1 |
0.0000 |
| 493 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 494 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 495 |
INJECTION SITE PAIN |
5 |
0.0000 |
| 496 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 497 |
CHEST PAIN |
3 |
0.0000 |
| 498 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 499 |
RHINORRHOEA |
1 |
0.0000 |
| 500 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 501 |
PAIN |
9 |
0.0000 |
| 502 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 503 |
ARTHRALGIA |
6 |
0.0000 |
| 504 |
INJURY |
1 |
0.0000 |
| 505 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 506 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 507 |
AGITATION |
1 |
0.0000 |
| 508 |
EPISTAXIS |
1 |
0.0000 |
| 509 |
DIABETES MELLITUS |
1 |
0.0000 |
| 510 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 511 |
HOSPITALISATION |
2 |
0.0000 |
| 512 |
DECREASED APPETITE |
3 |
0.0000 |
| 513 |
ARTHRITIS |
1 |
0.0000 |
| 514 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 515 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 516 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 517 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 518 |
TACHYCARDIA |
1 |
0.0000 |
| 519 |
DIARRHOEA |
7 |
0.0000 |
| 520 |
WEIGHT DECREASED |
3 |
0.0000 |
| 521 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 522 |
CONTUSION |
1 |
0.0000 |
| 523 |
NAUSEA |
8 |
0.0000 |
| 524 |
SYNCOPE |
1 |
0.0000 |
| 525 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 526 |
FLUSHING |
1 |
0.0000 |
| 527 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 528 |
SINUSITIS |
1 |
0.0000 |
| 529 |
ILLNESS |
1 |
0.0000 |
| 530 |
HAEMORRHAGE |
1 |
0.0000 |
| 531 |
ASTHMA |
1 |
0.0000 |
| 532 |
PALPITATIONS |
1 |
0.0000 |
| 533 |
CHILLS |
1 |
0.0000 |
| 534 |
FEELING ABNORMAL |
2 |
0.0000 |
| 535 |
JOINT SWELLING |
1 |
0.0000 |
| 536 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 537 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 538 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 539 |
PSORIASIS |
1 |
0.0000 |
| 540 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 541 |
DRUG INTERACTION |
1 |
0.0000 |
| 542 |
TREMOR |
1 |
0.0000 |
| 543 |
MYALGIA |
1 |
0.0000 |
| 544 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 545 |
ASTHENIA |
2 |
0.0000 |
| 546 |
DYSPNOEA |
3 |
0.0000 |
| 547 |
ANAEMIA |
1 |
0.0000 |
| 548 |
SOMNOLENCE |
1 |
0.0000 |
| 549 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 550 |
FATIGUE |
3 |
0.0000 |
| 551 |
COUGH |
1 |
0.0000 |